The role of genetic factors and serum protein binding in determining drug response as revealed by comprehensive drug surveillance.
D000017:ABO Blood-Group System; D001798:Blood Proteins / Q000378:metabolism; D003201:Computers; D003276:Contraceptives, Oral / Q000009:adverse effects; D005260:Female; D005826:Genetics, Medical; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced; D008297:Male; D010597:Pharmacogenetics; D011239:Prednisolone / Q000008:administration & dosage; D011241:Prednisone / Q000009:adverse effects*; D011247:Pregnancy; D011485:Protein Binding; D011605:Psychoses, Substance-Induced; D012709:Serum Albumin / Q000032:analysis*; D012712:Serum Globulins / Q000032:analysis; D013223:Statistics as Topic; D013548:Sweden; D013923:Thromboembolism / Q000097:blood*; D006113:United Kingdom; D014481:United States
D000017:ABO Blood-Group System; D001798:Blood Proteins; D003276:Contraceptives, Oral; D012709:Serum Albumin; D012712:Serum Globulins; D011239:Prednisolone; D011241:Prednisone